To continue using this website, please tell us a little about yourself:
I am a financial adviser
I am a discretionary fund manager / multimanager
I am a financial paraplanner
I work in financial services
I am a private investor
What would you like us to do with the funds you've selected
Change Share Class?
Show group factsheets
Download factsheet PDF
Buy this fund via Trustnet Direct
Add to Basket
Follow this fund on
The Biotech Growth Trust PLC seeks capital appreciation through investment in the worldwide biotechnology industry. Performance is measured against its benchmark index, the NASDAQ Biotechnology Index (sterling adjusted).
Orbimed Capital Since 23-Jun-1997
Manager biography not available
Geoffrey C. Hsu Since 19-May-2005
Geoffrey C. Hsu, CFA, is a General Partner of OrbiMed, having joined in 2002 as a public biotechnology analyst. Prior...
Richard D Klemm Since 19-May-2005
Richard D. Klemm, Ph.D., CFA, joined OrbiMed in 2000 as a public biotechnology company analyst. He completed a Ph.D....
Geoffrey C. Hsu
Geoffrey C. Hsu, CFA, is a General Partner of OrbiMed, having joined in 2002 as a public biotechnology analyst. Prior to joining OrbiMed, he worked as a financial...
Richard D Klemm
Richard D. Klemm, Ph.D., CFA, joined OrbiMed in 2000 as a public biotechnology company analyst. He completed a Ph.D. from the Massachusetts Institute of Technology in...
Top performing funds
Create a custom chart of this fund's performance
Check how your portfolios are currently performing
More performance charts
How does this fund compare against other funds in Biotechnology & Healthcare?
Ranking is for the main unit within the sector
View other funds in this sector
FE Risk scores allow you to see how risky a fund is in comparison with the FTSE
Frostrow Capital LLP, 25 Southampton Buildings, London, WC2A 1AL
0203 043 8889 (Fax Number)0203 008 4910 (Main Number)
The Biotech Growth Trust PLC
Risk Score 200.00
Learn more about FE Risk Scores
View all FE Risk Scores
Annual Management Charges: 0.65% of net assets plus 0.30% of market cap. plus £60,000;
All prices in Pence Sterling (GBX) unless otherwise specified. Price total return performance figures are calculated using closing mid prices and with net income (dividends) reinvested. NAV total return performance figures are calculated using fully diluted (where applicable) daily estimated NAV figures from Thomson Financial Datastream. Performance figures are shown in Pound Sterling (GBP). You can switch the fund’s native currency using the currency selector towards the top of this page.
You are being transferred to Trustnet Direct, which is run by Financial Express Investments Limited (authorised and regulated by the Financial Conduct Authority), where you will be able to complete this transaction. Trustnet Direct is an execution-only service and does not provide advice on the suitability of investments. You should seek independent financial advice if you are unsure.
Proceed to Trustnet Direct
Trustnet mobile website
13:00 | Monday, January 20, 2014
You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser. Close
© Trustnet Limited 2017. All Rights Reserved.
Data supplied in conjunction with Thomson Financial Limited, London Stock Exchange
Plc, StructuredRetailProducts.com and ManorPark.com